Saturday - May 16, 2026
The GLP-1 paradox: Rice study finds weight loss drugs may carry unexpected stigma
May 04, 2026
HOUSTON, Texas, May 4 -- Rice University posted the following news release:

* * *

The GLP-1 paradox: Rice study finds weight loss drugs may carry unexpected stigma

*

Glucagonlike peptide-1 (GLP-1) medications have taken over the national conversation around weight loss. From celebrity headlines to everyday conversations, GLP-1 drugs like Ozempic and Wegovy are often framed as breakthroughs and seen as powerful new tools that can help people los . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products